(Q90603872)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32205349%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

review article

3 references

13 July 2022

22 October 2022

Updated approaches against SARS-CoV-2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32205349%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

1 reference

1 reference

Haiou Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32205349%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Yunjiao Zhou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32205349%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Meng Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32205349%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Haizhou Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32205349%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Qiu Zhao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32205349%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

Jing Liu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32205349%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

publication date

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32205349%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

14 April 2020

21 May 2020

2 references

13 July 2022

22 October 2022

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32205349%20AND%20SRC:MED&resulttype=core&format=json

14 April 2020

13 July 2022

22 October 2022

Effects of chloroquine on viral infections: an old drug against today's diseases?

1 reference

12 December 2020

Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted

1 reference

12 December 2020

SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway

1 reference

12 December 2020

Arbidol as a broad-spectrum antiviral: an update

1 reference

12 December 2020

AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets

1 reference

12 December 2020

Convalescent plasma: new evidence for an old therapeutic tool?

1 reference

12 December 2020

Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow.

1 reference

12 December 2020

The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function

1 reference

12 December 2020

Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease

1 reference

12 December 2020

A Novel Coronavirus from Patients with Pneumonia in China, 2019

1 reference

12 December 2020

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

1 reference

12 December 2020

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

1 reference

12 December 2020

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

1 reference

12 December 2020

Drug treatment options for the 2019-new coronavirus (2019-nCoV)

1 reference

12 December 2020

First Case of 2019 Novel Coronavirus in the United States

1 reference

12 December 2020

A pneumonia outbreak associated with a new coronavirus of probable bat origin

1 reference

12 December 2020

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

1 reference

12 December 2020

Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV

1 reference

12 December 2020

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

1 reference

12 December 2020

Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment

1 reference

12 December 2020

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

1 reference

12 December 2020

Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein

1 reference

12 December 2020

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

1 reference

12 December 2020

Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses

1 reference

12 December 2020

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

1 reference

12 December 2020

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

1 reference

12 December 2020

The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

Epitopes for a 2019-nCoV vaccine

1 reference

12 December 2020

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

1 reference

12 December 2020

Clinical Characteristics of Coronavirus Disease 2019 in China

1 reference

12 December 2020

Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review

1 reference

12 December 2020

Convalescent plasma as a potential therapy for COVID-19

1 reference

12 December 2020

Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China

1 reference

12 December 2020

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

1 reference

12 December 2020

Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools

1 reference

12 December 2020

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

1 reference

12 December 2020

Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV

1 reference

12 December 2020

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

1 reference

12 December 2020

Traditional Chinese medicine for COVID-19 treatment

1 reference

12 December 2020

Timely development of vaccines against SARS-CoV-2

1 reference

12 December 2020

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

1 reference

12 December 2020

Compounds with therapeutic potential against novel respiratory 2019 coronavirus

1 reference

12 December 2020

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

1 reference

12 December 2020

Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.00483-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32205349%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

14 April 2020

COVIDWHO ID

covidwho-11740

0 references

1125778545

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

DOI

10.6084/M9.FIGSHARE.11961063

28 May 2020

PMC publication ID

7269512

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32205349%20AND%20SRC:MED&resulttype=core&format=json